Ponatinib: Targeting the T315I Mutation in Chronic Myelogenous Leukemia.
Posted by rob on January 19, 2012 under Uncategorized | 
Comments are off for this article
Ponatinib: Targeting the T315I Mutation in Chronic Myelogenous Leukemia.
Clin Adv Hematol Oncol. 2011 Dec;9(12):925-6
Authors: Shah NP
PMID: 22252660 [PubMed - in process]